Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Stem cell-based therapy for Parkinson's disease with a focus on human endometrium-derived mesenchymal stem cells.

Journal of cellular physiology - 1 Feb 2019

Bagheri-Mohammadi Saeid, Karimian Mohammad, Alani Behrang, Verdi Javad, Tehrani Rana Moradian, Noureddini Mahdi

Abstract excerpt

Parkinson's disease (PD) as an increasing clinical syndrome is a multifunctional impairment with systemic involvement. At present, therapeutic approaches such as l-3,4-dihydroxy-phenylalanine replacement therapy, dopaminergic agonist administration, and neurosurgical treatment intend to relieve PD symptoms which are palliative and incompetent in counteracting PD progression. These mentioned therapies have not...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cell Lineage
Share to Dopaminergic Neurons

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Endometrium

Share to Mesenchymal Stem Cell Transplantation

Share to Mesenchymal Stem Cells

Share to Nerve Regeneration

Share to Parkinson Disease

Share to Recovery of Function

Source

Identifiers

PMID: 30146713
DOI: 10.1002/jcp.27182

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Stem cell-based therapy for Parkinson's disease with a focus on human endometrium-derived mesenchymal stem cells.PMID 30146713Read ↗

Cell Therapy in Parkinson’s DiseaseSemantic proximity Read ↗

Menstrual blood derived endometrial stem cells alleviate neuroinflammation by modulating microglia polarization in cells and rats Parkinson’s disease modelsSemantic proximity Read ↗

Therapy With Mesenchymal Stem Cells in Parkinson DiseaseSemantic proximity Read ↗

Parkinson's Disease and Mesenchymal Stem Cells: Potential for Cell-Based TherapySemantic proximity Read ↗

Towards stem cell based therapies for Parkinson's diseaseSemantic proximity Read ↗

Induced pluripotent stem cells and Parkinson's disease: modelling and treatmentSemantic proximity Read ↗

Stem cell therapies for Parkinson’s diseaseSemantic proximity Read ↗

Stem-Cell-Based Strategies for the Treatment of Parkinson’s DiseaseSemantic proximity Read ↗

Using induced pluripotent stem cells for modeling Parkinson’s diseaseSemantic proximity Read ↗

Human Clinical-Grade Parthenogenetic ESC-Derived Dopaminergic Neurons Recover Locomotive Defects of Nonhuman Primate Models of Parkinson's Disease.Semantic proximity Read ↗

Developing Stem Cell Therapies for Parkinson’s Disease: Waiting Until the Time Is RightSemantic proximity Read ↗

Pre-clinical safety and efficacy of human induced pluripotent stem cell-derived products for autologous cell therapy in Parkinson’s diseaseSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.